Literature DB >> 2838531

Comparison of assays for antibody to HTLVI.

P M White1.   

Abstract

Indirect immunofluorescence, competitive radioimmunoassay, HTLV I-enzyme linked immunosorbent assay and gelatin particle agglutination Serodia-ATLA were compared in terms of their ability to detect antibody to human T cell leukaemia virus I (HTLV I). The sensitivities were 96.9%, 92%, 97.0%, and 100%, respectively, and the specificities 99.3%, 98.9%, 98.6%, and 96.3%. Particle agglutination was very simple to perform and was the most sensitive, though the least specific test. Antibody titres were 10-100 times higher when measured by particle agglutination than by other tests, and antibody titers were considerably higher in patients with neurological disease related to HTLV I than in those with other conditions. Serodia-ATLA is the method of choice for preliminary screening of specimens for antibody to HTLV I, but positive results must be confirmed by another technique.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2838531      PMCID: PMC1141556          DOI: 10.1136/jcp.41.6.700

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  11 in total

1.  The politics of alcohol.

Authors:  A Paton
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-05

2.  Demonstration of adult T-cell leukemia virus antigen in milk from three sero-positive mothers.

Authors:  K Kinoshita; S Hino; T Amagaski; S Ikeda; Y Yamada; J Suzuyama; S Momita; K Toriya; S Kamihira; M Ichimaru
Journal:  Gan       Date:  1984-02

3.  Adult T-cell lymphoma-leukaemia in Blacks from the West Indies.

Authors:  D Catovsky; M F Greaves; M Rose; D A Galton; A W Goolden; D R McCluskey; J M White; I Lampert; G Bourikas; R Ireland; A I Brownell; J M Bridges; W A Blattner; R C Gallo
Journal:  Lancet       Date:  1982-03-20       Impact factor: 79.321

4.  Human T-cell leukemia virus (HTLV) in the United Kingdom.

Authors:  M F Greaves; W Verbi; R Tilley; T A Lister; J Habeshaw; H G Guo; C D Trainor; M Robert-Guroff; W Blattner; M Reitz
Journal:  Int J Cancer       Date:  1984-06-15       Impact factor: 7.396

5.  A retrospective study on transmission of adult T cell leukemia virus by blood transfusion: seroconversion in recipients.

Authors:  K Okochi; H Sato; Y Hinuma
Journal:  Vox Sang       Date:  1984       Impact factor: 2.144

6.  Prenatal diagnosis of congenital rubella.

Authors:  F Daffos; F Forestier; L Grangeot-Keros; M Capella Pavlovsky; P Lebon; M Chartier; J Pillot
Journal:  Lancet       Date:  1984-07-07       Impact factor: 79.321

7.  A new agglutination test for serum antibodies to adult T-cell leukemia virus.

Authors:  M Ikeda; R Fujino; T Matsui; T Yoshida; H Komoda; J Imai
Journal:  Gan       Date:  1984-10

8.  Human T-cell leukaemia/lymphoma virus-associated lymphoreticular neoplasia in Jamaica.

Authors:  W A Blattner; W N Gibbs; C Saxinger; M Robert-Guroff; J Clark; W Lofters; B Hanchard; M Campbell; R C Gallo
Journal:  Lancet       Date:  1983-07-09       Impact factor: 79.321

9.  Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera.

Authors:  Y Hinuma; K Nagata; M Hanaoka; M Nakai; T Matsumoto; K I Kinoshita; S Shirakawa; I Miyoshi
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

10.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

Authors:  B J Poiesz; F W Ruscetti; A F Gazdar; P A Bunn; J D Minna; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

View more
  2 in total

1.  HTLV-1 infection: the clinical spectrum widens.

Authors:  R J Coleman; M Zuckerman; M Swash
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-04       Impact factor: 10.154

2.  Use of dried blood spots for the detection and confirmation of HTLV-I specific antibodies for epidemiological purposes.

Authors:  S P Parker; M B Taylor; A E Ades; W D Cubitt; C Peckham
Journal:  J Clin Pathol       Date:  1995-10       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.